News | February 08, 2022
Merck KGaA restructures life science business to support long-term growth
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
Quviviq is a dual orexin receptor antagonist, which blocks the binding of the wake-promoting neuropeptides orexins and is thought to turn down overactive wakefulness, as opposed to treatments that generally sedate the brain
It provides Covid-19 detection and Omicron surveillance in less than two hours
New capabilities on Philips Image Guided therapy mobile C-arm system – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment
It is the first monoclonal antibody drug for use in any animal species
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
Victor Chang Cardiac Research Institute (VCCRI) researcher recognized for his influential work on cardiovascular disease
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
